文章摘要
祁明雪,苏一帆,陈晨,等.依非韦伦、奈韦拉平或洛匹那韦 /利托那韦方案对艾滋病病毒 /艾滋病病人血脂代谢的长期影响[J].安徽医药,2024,28(5):1017-1024.
依非韦伦、奈韦拉平或洛匹那韦 /利托那韦方案对艾滋病病毒 /艾滋病病人血脂代谢的长期影响
Long-term effects of efavirenz, nevirapine,or lopinavir/ritonavir regimens on lipid metabolism in HIV-infected/AIDS patients
  
DOI:10.3969/j.issn.1009-6469.2024.05.036
中文关键词: 获得性免疫缺陷综合征  血脂异常  奈韦拉平  洛匹那韦 /利托那韦  依非韦伦  艾滋病  高脂血症
英文关键词: Acquired immunodeficiency syndrome  Dyslipidemias  Nevirapine  Lopinavir/ritonavir  Efavirenz  HIV/AIDS  Hyperlipidemia
基金项目:江苏省卫生健康委科研项目( ZDA2020014);南京市卫生科技发展专项资金项目( ZKX22040)
作者单位E-mail
祁明雪 南京中医药大学附属南京医院南京市第二医院感染科江苏南京 211103  
苏一帆 南京中医药大学附属南京医院南京市第二医院感染科江苏南京 211103  
陈晨 南京中医药大学附属南京医院南京市第二医院感染科江苏南京 211103  
钟明丽 南京医科大学公共卫生学院江苏南京 211166  
魏洪霞 南京中医药大学附属南京医院南京市第二医院感染科江苏南京 211103 wghongxia@sina.com 
摘要点击次数: 46
全文下载次数: 31
中文摘要:
      目的观察依非韦伦( EFV)、奈韦拉平( NVP)或洛匹那韦 /利托那韦( LPV/r)方案对艾滋病病毒( HIV)感染者 /艾滋病(AIDS)病人(简称 HIV/AIDS病人)血脂代谢的长期影响。方法采用回顾性队列研究的方法,以南京市第二医院 2013年 3月至 2018年 12月启动抗逆转录病毒治疗( ART)的成年 HIV/AIDS病人为研究对象,收集其人口学、临床基线和治疗随访数据,分析纳入对象在随访期间三酰甘油( TG)、总胆固醇( TC)、高密度脂蛋白胆固醇( HDL-C)、低密度脂蛋白胆固醇( LDL-C)、空腹血糖(FPG)以及 TC/HDL-C的检测水平及异常率的变化情况。结果与 EFV相比, NVP组在具体随访期间有较高 TG异常率和较低的 HDL-C、FPG和 TC/HDL-C异常率,两组总的血脂异常率随时间增加有明显变化;相较 EFV,LPV/r组在具体随访期间有较低的 FPG异常率和较高的 TG、TC以及 TC/HDL-C异常率,两组异常 TG、TC、HDL-C、FPG和 TC/HDL-C百分率随时间增加有明显变化。结论与 EFV相比, NVP可能与有利的脂质谱相关但 LPV/r可能对血脂危害更大,另外, EFV对血糖的影响高于其他两药,糖尿病病人应谨慎选择并做好监测。临床医生需要高度警惕 HIV/AIDS病人启动 ART治疗相关高脂血症所带来的潜在风险。
英文摘要:
      Objective To observe the long-term effects of efavirenz (EFV), nevirapine (NVP), or lopinavir/ritonavir (LPV/r) regimens on lipid metabolism in HIV-infected/AIDS patients (referred to as HIV/AIDS patients).Methods A retrospective cohort study was con-ducted to collect demographic, clinical baseline and treatment follow-up data from adult HIV/AIDS patients who initiated antiretroviraltherapy (ART) in Nanjing Second Hospital from March 2013 to December 2018, and to analyze triglyceride (TG), total cholesterol (TC),high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and low-density lipoprotein cholesterol (LDL-C) in the included subjects during the follow-up period. (HDL-C), low-density lipoprotein cholesterol (LDL-C), fasting glucose (FPG), and TC/HDL-C levels and abnormalities during the follow-up period.Results Compared with EFV, the NVP group had higher TG abnormality rates and lower HDL-C, FPG and TC/HDL-C abnormalities during specific follow-up periods, and the overall dyslipid-emia rates of the two groups increased significantly with time. Compared with EFV, the LPV/r group had lower rates of FPG abnormali-ties and higher rates of TG, TC and TC/HDL-C abnormalities during the specific follow-up period, and the percentages of TG, TC, HDL-C, FPG and TC/HDL-C abnormalities increased significantly over time in both groups.Conclusions Compared with EFV, NVP maybe related to favorable lipid profile, but LPV/r may be more harmful to blood lipids, in addition, the effect of EFV on blood glucose ishigher than that of the other two drugs, and diabetic patients should be carefully selected and monitored. Clinicians need to be vigilantabout the potential risks of hyperlipidemia associated with initiation of ART therapy in patients with HIV/AIDS.
查看全文   查看/发表评论  下载PDF阅读器
关闭

分享按钮